Progress of CD5-positive diffuse large B-cell lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 378-381, 2019.
Article
en Zh
| WPRIM
| ID: wpr-751411
Biblioteca responsable:
WPRO
ABSTRACT
CD5-positive diffuse large B-cell lymphoma (CD5+DLBCL) is a special type of DLBCL, which is characterized with later clinical staging, high-risk of relapse in extranodular tissues like bone marrow and central nervous system (CNS).Combined chemotherapy including rituximab and salvage autotransplantation/ allotransplantation can not significantly improve the prognosis. This article reviews the clinicopathological features, the possible pathogenesis, treatment status and dilemma in order to get the better understanding of CD5+DLBCL and avail the early diagnosis and individualized treatment.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Screening_studies
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2019
Tipo del documento:
Article